Impact of minor electrocardiographic ST-segment and/or T-wave abnormalities on cardiovascular mortality during long-term follow-up

American Journal of Cardiology

Volumn 91, Issue 9, 2003, Pages 1068-1074

  Greenland, Philip ^a   Xie, Xiaoyuan ^a   Liu, Kiang ^a   Colangelo, Laura ^a   Liao, Youlian ^a   Daviglus, Martha L ^a   Agulnek, Abby N ^a   Stamler, Jeremiah ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DEATH; DISEASE ASSOCIATION; DISEASE MARKER; ECG ABNORMALITY; FEMALE; FOLLOW UP; HAZARD ASSESSMENT; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RADIOGRAPHY; SEX DIFFERENCE; ST SEGMENT; ST SEGMENT DEPRESSION; T WAVE;

EID: 0037406206     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(03)00150-4     Document Type: Article

References (30)

1. Greenland P., Abrams J., Aurigemma G.P., Bond M.G., Clark L.T., Criqui M.H., Crouse J.R. III, Friedman L., Fuster V., Herrington D.M., et al. Prevention Conference V. Beyond secondary prevention identifying the high-risk patient for primary prevention, noninvasive tests of atherosclerotic burden . Circulation. 101:2000;111-116.
2. Smith S.C. Jr, Blair S.N., Bonow R.O., Brass L.M., Cerqueira M.D., Dracup K., Fuster V., Gotto A., Grundy S.M., Miller N.H., et al. AHA/ACC Scientific Statement. AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease 2001 update: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology . Circulation. 104:2001;1577-1579.
3. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals a randomised placebo-controlled trial . Lancet. 360:2002;7-22.
4. Matching the intensity of risk factor management with the hazard for coronary disease events. J Am Coll Cardiol. 27:1996;957-1047.
5. Ashley E.A., Raxwal V.K., Froelicher V.F. The prevalence and prognostic significance of electrocardiographic abnormalities. Curr Probl Cardiol. 25:2000;1-72.
6. Liao Y., Liu K., Dyer A., Schoenberger J.A., Shekelle R.B., Collette P., Stamler J. Sex differential in the relationship of electrocardiographic ST-T abnormalities to risk of coronary death 11.5 years follow-up findings of the Chicago Heart Association Detection Project in Industry . Circulation. 75:1987;347-352.
7. Kannel W.B., Anderson K., McGee D.L., Degatano L.S., Stampfer M.J. Nonspecific electrocardiographic abnormality as a predictor of coronary heart disease The Framingham Study . Am Heart J. 113:1987;370-376.
8. De Bacquer D., Pereira M., De Backer G., Henauw D., Kornitzer M. The predictive value of electrocardiographic abnormalities for total and cardiovascular disease mortality in men and women. Eur Heart J. 15:1994;1604-1610.
9. Atterhog J.H. A 5-year follow-up of young men with primary T-wave aberrations in their electrocardiograms. Acta Med Scand. 209:1981;75-82.
10. Sigurdsson E., Sigfusson N., Sigvaldason H., Thorgeirsson G. Silent ST-T changes in an epidemiologic cohort study - a marker of hypertension or coronary heart disease, or both The Reykjavik Study . J Am Coll Cardiol. 27:1996;1140-1147.
11. Burch G.E. Significance of certain early changes in the T-wave in coronary disease. JAMA. 165:1957;1781-1784.
12. Rose G., Baxter P.J., Reid D.D., McCartney P. Prevalence and prognosis of electrocardiographic findings in middle-aged men. Br Heart J. 40:1978;636-643.
13. Cullen K., Stenhouse N.S., Wearne K.L., Cumpston G.N. Electrocardiograms and 13 year cardiovascular mortality in Busselton Study. Br Heart J. 47:1982;209-221.
14. Bartel A., Heyden S., Tyroler H.A., Tabseh E., Cassel J.C., Hames C.G. Electrocardiographic predictors of coronary heart disease. Arch Intern Med. 128:1971;929-937.
15. Knutsen R., Knutsen S.F., Curb J.D., Reed D.M., Kautz J.A., Yano K. The predictive value of resting electrocardiograms for 12-year incidence of coronary heart disease in the Honolulu Heart Program. J Clin Epidemiol. 41:1988;293-302.
16. Stamler J., Rhomberg P., Schoenberger J.A., Shekelle R.B., Dyer A., Shekelle S., Stamler R., Wannamaker J. Multivariate analysis of the relationship of seven variables to blood pressure findings of the Chicago Heart Association Detection Project in Industry, 1967-1972 . J Chronic Dis. 28:1975;527-548.
17. De Bacquer D., De Backer G., Kornitzer M., Myny K., Doyen Z., Blackburn H. Prognostic value of ischemic electrocardiographic findings for cardiovascular mortality in men and women. J Am Coll Cardiol. 32:1998;680-685.
18. De Bacquer D., De Backer G., Kornitzer M., Blackburn H. Prognostic value of ECG findings for total, cardiovascular disease, and coronary heart disease death in men and women. Heart. 80:1998;570-577.
19. Ostrander L.D. Jr. The relation of "silent" T-wave inversion to cardiovascular disease in an epidemiologic study. Am J Cardiol. 25:1970;325-328.
20. Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events final report of the Pooling Project . J Chron Dis. 31:1978;201-306.
21. Berkson D.M., Stamler J., Stevens E., Soyugenc R., Smoot E. The electrocardioanalyzer. Israeli J Med Sci. 5:1969;687-690.
22. Prineas R.J., Crow R.S., Blackburn H. The Minnesota Code Manual of Electrocardiographic Findings Standards and Procedures for Measurement and Classification . 1982;John Wright-PSG Inc, Littleton, MA.
23. Macfarlane P.W. Minnesota coding and the prevalence of ECG abnormalities. Heart. 84:2000;582-584.
24. Stamler R., Stamler J., Schoenberger J.A., Shekelle R.B., Collette P., Shekelle S., Dyer A., Garside D., Wannamaker J. Relationship of glucose tolerance to prevalence of ECG abnormalities and to 5-year mortality from cardiovascular disease. Findings of the Chicago Heart Association Detection Project in Industry. J Chronic Dis. 32:1979;817-828.
25. International Classification of Diseases, 8th revision. Adapted for use in the United States (ICDA). Vol. I (PHS) 1693. Washington, DC: National Center for Health Statistics, 1967:49.
26. Therneau T.M., Grambsch P.M. Modeling Survival Data. Extending The Cox Model. 2000;130-139 Springer, New York.
27. Daviglus M.L., Liao Y., Greenland P., Greenland P., Dyer A.R., Liu K., Xie X., Huang C.F., Prineas R.J., Stamler J. Association of nonspecific minor ST-T abnormalities with cardiovascular mortality. The Chicago Western Electric Study. JAMA. 281:1999;530-536.
28. Davis C.E., Rifkind B.M., Brenner H., Gordon D.J. A single cholesterol measurement underestimates the risk of coronary heart disease an empirical example from the Lipid Research Clinics Mortality Follow-up Study . JAMA. 264:1990;3044-3046.
29. Sekikawa A., Kuller L.H. Striking variation in coronary heart disease mortality in the United States among African-American and white women aged 45-54 by state. J Women's Health Gender Based Med. 9:2000;545-558.
30. Lloyd-Jones D.M., Martin D.O., Larsen M.G., Levy D. Accuracy of death certificates for coding coronary heart disease as the cause of death. Ann Intern Med. 129:1998;1020-1026.